John J V Mc Murray is an expert in Cardiology at University of Glasgow (United Kingdom). As of October 2026, ScienceLeadR ranks John J V Mc Murray in the top 1% of experts worldwide for Heart Failure, Ventricular Dysfunction and Glucose Metabolism Disorders. John J V Mc Murray has authored 1,978 publications, the most recent in 2026, and is an investigator in 76 clinical trials, 2 of them ongoing. SLR score: 9,593 (community average: 125). How the SLR is computed.

LeadR Profile

John J V Mc Murray University of Glasgow United Kingdom
9 593 ScienceLeadR Reputation 9593
Network Map

Cardiology

Subspecialties: Endocrinology - Public Health - Nephrology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1992 - 2026

Source: PubMed

Queen Elizabeth University Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 1978

Citations

Citations: 291 563 1st author: 94 Last author: 522 Unique author: 43


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Mitral regurgitation in patients with heart failure and reduced ejection fraction: insights from GALACTIC-HF.
PMID 41771063 — heart failure, heart, heart failure, systolic, mitral valve insufficiency
Eur J Heart Fail20260
Bayesian Survival Analysis for Heart Failure Clinical Trials in the Presence of Competing Risks.
PMID 42944671 — heart failure, heart, survival analysis
JACC Heart Fail20260
NT-proBNP and Clinical Outcomes in Patients With HFrEF According to Atrial Fibrillation: Insights From QUEST.
PMID 42944673 — hospitalization, heart failure, heart, atrial fibrillation, heart failure, systolic, natriuretic peptides, therapeutics
JACC Heart Fail20260
Short-term effects of combinations of heart failure therapies on blood pressure, kidney function and serum potassium.
PMID 42675244 — blood, serum, heart failure, molecular biology, heart, blood pressure, heart failure, diastolic, kidney, heart failure, systolic, therapeutics
Nat Med Top journal20260
Early Discharge Strategy Including Subcutaneous Furosemide in Hospitalized Heart Failure.
PMID 42872757 — heart failure, heart, cardiology, diuretics, furosemide
J Am Coll Cardiol20261

Clinical Studies 76

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 47
Phase 2 13
Phase 4 10
N/A 6

By status:

Completed 65
Terminated 8
Active not recruiting 2
Unknown 1

By type:

Interventional 74
Observational 2

By Monocentric/Multicentric:

monocentric 18
multicentric2to4 4
multicentric5to9 0
multicentricup10 54

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Targeted Assessment in High Risk paTients With dIAbetes to ideNtify Undiagnosed Heart Failure
NCT05705869 — diabetes mellitus, heart failure, heart, cardiovascular diseases, secondary care, signs and symptoms, symptom assessment, diabetes mellitus, type 1, diabetes mellitus, type 2
N/AActive not recruiting2022
DAPAgliflozin Versus Thiazide Diuretic in Patients With Heart Failure and Diuretic RESISTance
NCT04860011 — sodium-glucose transport proteins, heart failure, heart, multiple chronic conditions, tablets, metolazone, diuretics, thiazides
Phase 3Active not recruiting2021

LeadR Networks

Main global connection map